Every company, grouped.

Listed and private companies with longevity exposure, sourced and dated. Grouped by intervention category, with a second view by primary exchange.

By category

ASX listed

1

First FDA-approved MSC product (Ryoncil).

AI drug discovery

1

Generative-AI drug discovery (Pharma.AI).

GLP-1 and metabolic

1

Tirzepatide + oral orforglipron; XPRIZE Healthspan sponsor.

Geroscience

1

Senolytics, clearing senescent cells.

By exchange

ASX

1

First FDA-approved MSC product (Ryoncil).

HKEX

1

Generative-AI drug discovery (Pharma.AI).

NASDAQ

1

Senolytics, clearing senescent cells.

NYSE

1

Tirzepatide + oral orforglipron; XPRIZE Healthspan sponsor.